P3 Health Partners Inc. (PIII) intrinsic value & 10-year financials
P3 Health Partners Inc. (PIII) has no Graham intrinsic value right now because the formula needs positive earnings. Over the last 8 fiscal years revenue grew 46.9% a year to $1.5B, with an average return on invested capital of -349.8%.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $4.14
- Market cap
- $13.5M
- Revenue (FY2025)
- $1.5B
- Revenue growth (8-yr CAGR)
- 46.9%
- ROIC (10-yr avg)
- -349.8%
- Free cash flow (FY2025)
- —
PIII 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | $1.5B | -$147.9M | -$45.26 | — | -18.5% | -160.3% |
| FY2024 | $1.5B | -$135.8M | -$1.08 | — | -21.4% | -139.3% |
| FY2023 | $1.3B | -$57.8M | -$0.63 | -$77.9M | -13.3% | -104.3% |
| FY2022 | $1.0B | -$270.1M | -$0.00 | -$128.3M | -148.7% | -995.3% |
| FY2021 | $793.4M | — | — | — | — | — |
| FY2020 | $491.1M | -$31.4M | — | -$27.5M | -5.8% | — |
| FY2019 | $145.5M | -$42.0M | — | -$29.7M | -27.2% | — |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
P3 Health Partners Inc. revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
P3 Health Partners Inc. has historically struggled to out-earn its cost of capital, averaging just -63.8% ROIC.
P3 Health Partners Inc. capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Under Benjamin Graham's formula using SEC EDGAR fundamentals, P3 Health Partners Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $-1503.34 per share.